EMA — authorised 29 January 2010
- Status: approved
EMA authorised Rapaflo on 29 January 2010
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 29 January 2010.
AbbVie is the originator. The local marketing authorisation holder may differ — check the official source linked above.